Centre Asset Management LLC lessened its stake in HCA Healthcare Inc (NYSE:HCA) by 87.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 10,917 shares of the company’s stock after selling 75,900 shares during the quarter. Centre Asset Management LLC’s holdings in HCA Healthcare were worth $1,614,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the stock. Steward Partners Investment Advisory LLC increased its position in HCA Healthcare by 2.4% during the 3rd quarter. Steward Partners Investment Advisory LLC now owns 4,034 shares of the company’s stock valued at $485,000 after purchasing an additional 94 shares during the period. Cibc Bank USA increased its position in HCA Healthcare by 1.7% during the 3rd quarter. Cibc Bank USA now owns 5,656 shares of the company’s stock valued at $681,000 after purchasing an additional 96 shares during the period. NEXT Financial Group Inc increased its position in HCA Healthcare by 32.1% during the 3rd quarter. NEXT Financial Group Inc now owns 424 shares of the company’s stock valued at $51,000 after purchasing an additional 103 shares during the period. Trust Co. of Toledo NA OH increased its position in HCA Healthcare by 6.2% during the 4th quarter. Trust Co. of Toledo NA OH now owns 2,093 shares of the company’s stock valued at $309,000 after purchasing an additional 123 shares during the period. Finally, Synovus Financial Corp increased its position in HCA Healthcare by 17.6% during the 3rd quarter. Synovus Financial Corp now owns 867 shares of the company’s stock valued at $104,000 after purchasing an additional 130 shares during the period. 69.43% of the stock is currently owned by institutional investors.

A number of research analysts have commented on the stock. ValuEngine raised shares of HCA Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Bank of America raised shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a research report on Friday, December 6th. JPMorgan Chase & Co. raised their target price on shares of HCA Healthcare from $157.00 to $186.00 and gave the company an “overweight” rating in a research report on Friday, December 20th. Barclays raised their target price on shares of HCA Healthcare from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Wednesday, October 30th. Finally, Deutsche Bank assumed coverage on shares of HCA Healthcare in a research report on Friday, January 3rd. They set a “buy” rating and a $140.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $156.07.

Shares of NYSE:HCA traded up $0.75 during trading on Tuesday, reaching $147.91. The stock had a trading volume of 1,174,641 shares, compared to its average volume of 1,075,320. HCA Healthcare Inc has a one year low of $110.31 and a one year high of $150.17. The company has a market capitalization of $49.91 billion, a P/E ratio of 15.14, a PEG ratio of 1.13 and a beta of 0.92. The firm’s 50-day simple moving average is $144.98 and its 200 day simple moving average is $133.17.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, October 29th. The company reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.13 by $0.10. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. The business had revenue of $12.69 billion for the quarter, compared to analysts’ expectations of $12.48 billion. During the same period last year, the business earned $2.16 EPS. The company’s revenue was up 10.9% compared to the same quarter last year. As a group, analysts forecast that HCA Healthcare Inc will post 10.53 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 2nd were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.08%. The ex-dividend date of this dividend was Friday, November 29th. HCA Healthcare’s dividend payout ratio is currently 16.38%.

In related news, insider Michael S. Cuffe sold 5,891 shares of HCA Healthcare stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $147.04, for a total value of $866,212.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jon M. Foster sold 19,477 shares of HCA Healthcare stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $132.35, for a total transaction of $2,577,780.95. Following the completion of the sale, the insider now owns 10,015 shares of the company’s stock, valued at $1,325,485.25. The disclosure for this sale can be found here. Insiders sold a total of 48,511 shares of company stock worth $6,592,095 over the last 90 days. Company insiders own 2.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Is it Safe to Invest in Commodities?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.